Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia

Psychiatry Research

Volumn 227, Issue 2-3, 2015, Pages 265-269

  Suzuki, Takefumi ^a,b   Uchida, Hiroyuki ^a,c   Sakurai, Hitoshi ^a,b   Ishizuki, Tomomi ^a,d   Tsunoda, Kenichi ^a,e   Takeuchi, Hiroyoshi ^a,c   Mimura, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b Inokashira Hospital   (Japan)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d Department of Psychiatry   (Japan)

^e Minamihannou Hospital   (Japan)

Author keywords

Clinical global impression; Global assessment of functioning; Outcome; Positive and negative syndrome scale; Schizophrenia

Indexed keywords

ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL (TOPIC); CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; LONGITUDINAL STUDY; OBSESSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION; SUICIDAL IDEATION; SYSTEMATIC REVIEW; PSYCHOLOGICAL RATING SCALE; STANDARDS;

BRIEF PSYCHIATRIC RATING SCALE; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 84929134079     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.02.024     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington D.C. fourth edition.
2. Birchwood M., Smith J., Cochrane R., Wetton S., Copestake S. The social functioning scale: the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 1990, 157:853-859.
3. Busner J., Targum S.D. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007, 4:28-37.
4. Fervaha G., Zakzanis K.K., Foussias G., Graff-Guerrero A., Agid O., Remington G. Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry 2014, 71:1058-1065.
5. Furukawa T.A., Levine S.Z., Tanaka S., Goldberg Y., Samara M., Davis J.M., Cipriani A., Leucht S. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry 2015, 72:14-21. 10.1001/jamapsychiatry.2014.2127.
6. Gaite L., Vázquez-Barquero J.L., Herrán A., Thornicroft G., Becker T., Sierra-Biddle D., Ruggeri M., Schene A., Knapp M., Vázquez-Bourgon J., EPSILON Group Main determinants of global assessment of functioning score in schizophrenia: a European multicenter study. Comprehensive Psychiatry 2005, 46:440-446.
7. Goldman M., DeQuardo J.R., Tandon R., Taylor S.F., Jibson M. Symptom correlates of global measures of severity in schizophrenia. Comprehensive Psychiatry 1999, 40:458-461.
8. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW Publ No ADM 76-338). Rockville, MD, US Department of Heath, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp. 218-222.
9. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 1984, 10:388-398.
10. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
11. Lieberman J.A., Drake R.E., Sederer L.I., Belger A., Keefe R., Perkins D., Stroup S. Science and recovery in schizophrenia. Psychiatric Services 2008, 59:487-496.
12. Leifker F.R., Patterson T.L., Heaton R.K., Harvey P.D. Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophrenia Bulletin 2011, 37:334-343.
13. Leucht S., Kane J.M., Kissling W., Hamann J., Etschel E., Engel R.R. What does the PANSS mean?. Schizophrenia Research 2005, 79:231-238.
14. Leucht S., Kane J.M., Etschel E., Kissling W., Hamann J., Engel R.R. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 2006, 31:2318-2325.
15. Levine S.Z., Rabinowitz J., Engel R., Etschel E., Leucht S. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI. Schizophrenia Research 2008, 98:318-322.
16. Morosini P.L., Magliano L., Brambilla L., Ugolini S., Pioli R. Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica 2000, 101:323-329.
17. Niv N., Cohen A.N., Sullivan G., Young A.S. The MIRECC version of the global assessment of functioning scale: reliability and validity. Psychiatric Services 2007, 58:529-535.
18. Overall J.E., Gorham D.R. The brief psychiatric rating scale (BPRS): recent development in ascertainment and scaling. Psychopharmacology Bulletin 1988, 24:97-99.
19. Rabinowitz J., Mehnert A., Eerdekens M. To what extent do the PANSS and CGI-S overlap?. Journal of Clinical Psychopharmacology 2006, 26:303-307.
20. Rabinowitz J., Levine S., Martinez G. Concordance between measures of functioning, symptoms, and change: examining the GAF, CGI-S, CGI-C, and PANSS. Journal of Clinical Psychopharmacology 2010, 30:478-480.
21. Rosen A., Hadzi-Pavlovic D., Parker G. The life skills profile: a measure assessing function and disability in schizophrenia. Schizophrenia Bulletin 1989, 15:325-337.
22. Samara M.T., Engel R.R., Millier A., Kandenwein J., Toumi M., Leucht S. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. European Neuropsychopharmacology 2014, 24:1767-1772. 10.1016/j.euroneuro.2014.08.009.
23. Schneider L.C., Struening E.L. SLOF: a behavioral rating scale for assessing the mentally ill. Social Work Research & Abstracts 1983, 19:9-21.
24. Smith G.N., Ehmann T.S., Flynn S.W., MacEwan G.W., Tee K., Kopala L.C., Thornton A.E., Schenk C.H., Honer W.G. The assessment of symptom severity and functional impairment with DSM-IV axis V. Psychiatric Services 2011, 62:411-417.
25. Suzuki T., Uchida H., Watanabe K., Kashima H. Treatment target in schizophrenia: a critical review and a clinical suggestion. Psychopharmacology Bulletin 2008, 41:80-102.
26. Suzuki T., Uchida H., Nomura K., Takeuchi H., Nakajima S., Tanabe A., Yagi G., Watanabe K., Kashima H. Novel rating scales for schizophrenia-targeted inventory on problems in schizophrenia (TIP-Sz) and functional assessment for comprehensive treatment of schizophrenia (FACT-Sz). Schizophrenia Research 2008, 106:328-336.
27. Suzuki T., Takeuchi H., Nakajima S., Nomura K., Uchida H., Yagi G., Watanabe K., Kashima H. Magnitude of rater differences in assessment scales for schizophrenia. Journal of Clinical Psychopharmacology 2010, 30:607-611.
28. Suzuki T. Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review. Psychopharmacology Bulletin 2011, 44:18-31.
29. Wallace C.J., Liberman R.P., Tauber R., Wallace J. The independent living skills survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bulletin 2000, 26:631-658.
30. Wykes T., Stuart E. The measurement of social behavior in psychiatric patients: and assessment of the reliability and validity of the SBS schedule. British Journal of Psychiatry 1986, 148:1-11.